Nutex Health Inc.
NUTX
$176.00
$7.584.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 981.20M | 792.19M | 624.28M | 479.95M | 292.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 981.20M | 792.19M | 624.28M | 479.95M | 292.00M |
| Cost of Revenue | 420.80M | 364.79M | 299.96M | 264.72M | 205.78M |
| Gross Profit | 560.39M | 427.40M | 324.32M | 215.23M | 86.22M |
| SG&A Expenses | 180.79M | 168.10M | 87.45M | 58.48M | 40.26M |
| Depreciation & Amortization | 20.62M | 20.59M | 19.88M | 18.97M | 18.37M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 622.21M | 553.48M | 407.29M | 342.17M | 264.41M |
| Operating Income | 358.98M | 238.70M | 216.99M | 137.78M | 27.58M |
| Income Before Tax | 327.54M | 201.02M | 181.19M | 109.83M | -29.54M |
| Income Tax Expenses | 64.29M | 41.74M | 35.04M | 15.02M | 2.87M |
| Earnings from Continuing Operations | 263.25 | 159.29 | 146.15 | 94.81 | -32.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -142.68M | -102.94M | -72.48M | -42.71M | -8.73M |
| Net Income | 120.57M | 56.34M | 73.68M | 52.10M | -41.13M |
| EBIT | 358.98M | 238.70M | 216.99M | 137.78M | 27.58M |
| EBITDA | 379.61M | 259.30M | 236.87M | 156.75M | 45.96M |
| EPS Basic | 20.88 | 10.88 | 13.76 | 9.94 | -9.37 |
| Normalized Basic EPS | 10.60 | 4.63 | 8.46 | 5.84 | -0.91 |
| EPS Diluted | 19.27 | 9.79 | 12.67 | 9.43 | -9.38 |
| Normalized Diluted EPS | 9.50 | 3.88 | 7.71 | 5.50 | -0.91 |
| Average Basic Shares Outstanding | 23.58M | 21.98M | 20.95M | 20.13M | 19.13M |
| Average Diluted Shares Outstanding | 25.42M | 23.34M | 22.32M | 20.47M | 19.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 6.11% | 13.07% | 9.99% | 0.92% | -1.17% |